Author(s):
Prasanta Kumar Mohapatra, Janki Manohar, Pankaj Singh Patel, Mandeep Kumar Gupta, Bibhuti Prasad Rath
Email(s):
mohapatra.kjr@gmail.com
DOI:
10.52711/0974-360X.2021.00330 
Address:
Prasanta Kumar Mohapatra1*, Janki Manohar2, Pankaj Singh Patel 1, Mandeep Kumar Gupta1, Bibhuti Prasad Rath3
1Moradabad Educational Trust Group of Institutions Faculty of Pharmacy, Moradabad, Uttar Pradesh - 244001, India.
2Lydia College of Pharmacy, Ravulapalem, Andhra Pradesh - 533238, India.
3Gayatri Institute of Science and Technology, Rayagada, Odisha- 765022, India.
*Corresponding Author
Published In:
Volume - 14,
Issue - 4,
Year - 2021
ABSTRACT:
The aim of the strategy to formulate the pulsatile drug delivery system using terbutaline sulfate by direct compression technique and evaluate the effects of formulation and dissolution medium on the behavior of drug release, and to clarify the drug release mechanism based on acquiring results. Pulsatile release tablets include a drug and disintegrating agent-containing core and swellable external layers for slow down drug release, then rupturing the nearby surrounding outer layer for fast release. Core tablets prepared using disintegrating agent by direct compression method and coated with polymers like HPMC K100M, ethyl cellulose, karaya gum in different quantities. Several physical parameters of the tablets evaluated such as stiffness, thickness, friability, weight variation, disintegration, drug content and dissolution test. Terbutaline sulfate released from bi-layered tablets with pulsatile behaviors. In-vitro drug release rate readings showed that F3 and F6 are best based on the less quantity of drug release during the lag time (11% and 14% in 5 h). So, from the result, the F6 has nominated the best formulation. Thus, by the direct compression method prepared, coated tablets before drug release with an obvious lag time is possibly useful preparation for the medication of osteoarthritis, rheumatoid arthritis, dysmenorrhea, asthma which follows a circadian rhythm. It confirmed that eroding, diffusion, and swelling mechanisms were responsible for drug release. Ultimate pulsatile release activities may be done by modifying polymeric membrane quantities and proportions to meet the condition of pulsatile activities.
Cite this article:
Prasanta Kumar Mohapatra, Janki Manohar, Pankaj Singh Patel, Mandeep Kumar Gupta, Bibhuti Prasad Rath. Physicochemical Characterization of Bi-Layered Terbutaline Sulfate Tablets for Chronotherapeutic Pulsatile Drug Delivery Design Based on Natural and Synthetic Polymer using Direct Compression Technique. Research Journal of Pharmacy and Technology. 2021; 14(4):1867-4. doi: 10.52711/0974-360X.2021.00330
Cite(Electronic):
Prasanta Kumar Mohapatra, Janki Manohar, Pankaj Singh Patel, Mandeep Kumar Gupta, Bibhuti Prasad Rath. Physicochemical Characterization of Bi-Layered Terbutaline Sulfate Tablets for Chronotherapeutic Pulsatile Drug Delivery Design Based on Natural and Synthetic Polymer using Direct Compression Technique. Research Journal of Pharmacy and Technology. 2021; 14(4):1867-4. doi: 10.52711/0974-360X.2021.00330 Available on: https://www.rjptonline.org/AbstractView.aspx?PID=2021-14-4-6
REFERENCES:
1. Hemalatha V, Kumar PPS, Naidu MRL, Priyanka et al. Formulation and evaluation of pulsatile drug delivery system of Celecoxib. World Journal of Pharmaceutical Research. 2016; 5(2): 1110-1119.
2. Hochhaus G, Mollmann H. Pharmacokinetic/pharmacodynamic characteristics of the beta-2-agonists Terbutaline, Salbutamol and Fenoterol. International journal of clinical pharmacology, therapy, and toxicology. 1992; 30(9): 342-362.
3. Naik VV, Ankarao A, Anil Babu K, Neelima P.V.A, Anil Babu G et al. Formulation and evaluation of Valsartan pulsincap drug delivery system. International Journal of Pharmacy and Analytical Research. 2015; 4(1): 41-47.
4. Jain D, Raturi R, Jain V, Bansal P, Singh R. Recent technologies in pulsatile drug delivery systems. Biomatter. 2011; 1(1): 57-65.
5. Nabin K, Biswajit B, Patel J, Patel KM et al. Preparation and evaluation of pulsatile drug delivery system containing Terbutaline sulphate. International Research Journal of Pharmacy. 2011; 2(2): 113-119.
6. Nandedkar S.Y, Wagh RD, Bauskar MD et al. Formulation design and optimization of pulsatile release tablet of Acebrophylline with swelling and erodiable layers for treatment of nocturnal bronchial asthma. International Journal of Pharmaceutical Sciences and Research. 2011; 2(12): 3100-3108.
7. Baghel P, Roy A, Chandrakar S, Bahadur S. Pulsatile drug delivery system: A promising delivery system. Research Journal of Pharmaceutical Dosage Forms and Technology. 2013; 5(3): 111-114.
8. Mahajan AN, Shah DA, Patel KT et al. Studies in formulation development of chronotherapeutics dosage of model drug. Scholars Research Library. 2011; 3(4): 227-240.
9. Fatima SN, Mohammed S et al. Formulation and in-vitro evaluation of meloxicam pulsin cap for pulsatile drug delivery. International Journal of Innovative Pharmaceutical Sciences and Research. 2017; 5(8): 126-138.
10. Vijaya Vani Ch.S, Rao MV.U, Bhavani D et al. Formulation and evaluation of Montelukast sodium pulsatile drug delivery system by core in cup method. International Journal of Pharmacy Review and Research. 2015; 5(1): 15-23.
11. Sudhamani T, Radhakrishnan M, Mallela D, and Ganesan V. Chronotherapeutic floating pulsatile drug delivery: An approach for time-specific and site-specific absorption of drugs. Research Journal of Pharmacy and Technology. 2011; 4(5): 685-690.
12. Gajanan N.P, Borate S, Ranpise A, Mandage Y, Thanki K, Rao M et al. Design, evaluation and comparative study of pulsatile release from tablet and capsule dosage forms. Iranian Journal of Pharmaceutical Sciences. 2009; 5(3): 119-128.
13. Gohel MC, Parikh RK, Patel LD, Patel VP Gami SV et al. Design and evaluation study of pulsatile release tablets of Metoprolol succinate. Pharma Science Monitor-An International Journal Pharmaceutical Sciences. 2012; 3(2): 171-181.
14. Jadhav TS, Thombre NA, Kshirsagar SJ. Pulsatile drug delivery system using core-in-cup approach: a review, Pharmaceutical and Biological Evaluations. 2016; 3(3): 1-9.
15. Seidler FJ, Rahman AA, Tate CA, Nyska A, Rincavage Hl, Slotkin TA, Rhodes MC et al. Terbutaline is a developmental neurotoxicant: effects on neuroproteins and morphology in cerebellum, hippocampus, and somatosensory cortex. The Journal of Pharmacology and Experimental Therapeutics. 2004; 308(2): 529-537.
16. Thakare VM, Gandhi BR, Tekade BW, Sadaphal KP et al. Formulation and evaluation of pulsatile drug delivery system for chronobiological disorder: asthma. International Journal of Drug Delivery. 2011; 3: 348-356.
17. Dharmamoorthy G, Nandhakumar. Chronotherapeutics: a range of newer drug delivery approaches for better patient compliance, International Journal of Applied Biology and Pharmaceutical Technology. 2011; 2(4): 110-120.
18. Vishnu PP, Sharma JVC, Avinash A et al. Formulation and evaluation of Terbutaline sulphate by pulsatile drug delivery system. International Journal of Biopharmaceutics. 2016; 7(1): 7-12.
19. Kumar A, Sonam R. Pulsatile drug delivery system: method and technology review, International Journal of Drug Development and Research. 2012; 4(4): 95-107.
20. Hamed Md.M, Rafiq M, Ali N, Sayeed A et al. Pulsatile drug delivery systems: recent technology. International Journal of Pharmaceutical Sciences and Research. 2013; 4(3): 960-969.
21. Mahajan AN, Pancholi SS. Formulation and evaluation of timed delayed capsule device for chronotherapeutic delivery of terbutaline sulphate. ARS Pharmaceutica. 2010; 50(4): 215-223.
22. Rao NGR, Panchal H, Hadi MA. Formulation and evaluation of biphasic drug delivery system of Terbutaline sulphate for chronotherapy. International Journal of Pharma and Bio Sciences. 2012; 3(3): 626-637.
23. Singh HN, Saxena S, Singh S, Yadav AK. Pulsatile drug delivery system: Drugs used in the pulsatile formulations. Research Journal of Pharmaceutical Dosage Forms and Technology. 2013; 5(3): 115-121.
24. Emami J, Boushehri MAS, Varshosaz J, Eisaei A. Preparation and characterization of a sustained release buccoadhesive system for delivery of Terbutaline sulphate. Research in Pharmaceutical Sciences. 2013; 8(4): 219-231.
25. Ramani Nd, Kumar Pb, Kola R et al. Formulation and in-vitro evaluation of Terbutaline sulphate sustained release tablets. Indian Journal of Research in Pharmacy and Biotechnology. 2013; 1(5): 621-624.
26. Kumar TMP, Kumar HGS. Novel core in cup buccoadhesive systems and films of Terbutaline sulphate development and in-vitro evaluation. Asian Journal of Pharmaceutical Sciences. (2006) 1(3-4):175-187.
27. Gobade NG, Koland M, Harish KH. Asymmetric membrane osmotic capsules for Terbutaline sulphate. Indian Journal of Pharmaceutical Sciences. 2012; 74(1): 69-72.
28. Gupta VRM, Patil SS et al. Development and in-vitro evaluation of chronomodulated delivery systems of Terbutaline sulphate. International Journal of Research and Development in Pharmacy and Life Sciences. 2016; 5(4): 2280-2290.
29. Hadi MA, Saleem MD, Rao AS, Rao VU. Surface response methodology for development and optimization of Aceclofenac pulsatile release drug delivery system. Asian Journal of Pharmacy and Technology. 2014; 4(2): 74-82.
30. Patil V, Nagesh C, Praveen K, Rekha S, Chandrasekhara S et al. Pulsatile drug delivery system of Terbutaline sulphate; using ph sensitive polymer. American Journal of Advanced Drug Delivery. 2013; 1(4): 635-650.
31. Patil SS, Patil SV, Lade PD, Janugade BU et al. Formulation and evaluation of press-coated Montelukast sodium tablets for pulsatile drug delivery system. International. Journal of chem tech research. 2009; 1(3): 690-691.
32. Patel J, Patel D, Vachhani S, Prajapati ST, and Patel CN. Current status of technologies and devices for chronotherapeutic drug delivery systems. Research Journal of Pharmacy and Technology. 2010; 3(2): 344-352.
33. Nawaj SS, Khan M, Khan Dr. GJ, Sohel A. Design, development and evaluation of press coated floating pulsatile tablet of antihypertensive agent. Research Journal of Pharmacy and Technology. 2018; 11(3): 921-929.
34. Archana A, Manikanta AK, Shetty KSM. Formulation development and evaluation of Sumatriptan pulsatile drug delivery using pulsincap technology. Research Journal of Pharmacy and Technology. 2013; 6(12): 1375-1379.
35. Kalyani V, Basanthi K, and Murthy TEGK. Formulation and evaluation of modified pulsincap drug delivery system for chronotherapeutic delivery of Montelukast sodium. Research Journal of Pharmaceutical Dosage Forms and Technology. 2014; 6(4): 225-229.
36. Rao NGR, Hadi MA, Panchal H. Formulation and evaluation of biphasic drug delivery system of Montelukast sodium for chronotherapy. International Journal of Pharmaceutical and Chemical Sciences. 2012; 1(3): 1256-1265.
37. Patel VD, Yegnoor AK. Development and evaluation of Celecoxib core in cup tablets for pulsatile drug delivery. Research Journal of Pharmacy and Technology. 2017; 10(3): 755-764.
38. Chowdary KPR, Shobarani RH, Narasu L, Bhat A et al. Formulation and evaluation of chronopharmaceutical drug delivery of Theophylline for nocturnal asthma. International Journal of Pharmacy and Pharmaceutical Sciences. 2011; 3(2): 204-208.
39. Costa P, Lobo J.M.S. Modeling and comparison of dissolution profiles. European Journal of Pharmaceutical Sciences. 2001; 13: 123-133.
40. Dighe PA, Kharat AR, Patil SV, Ramteke KH et al. Mathematical models of drug dissolution: a review. Scholars Academic Journal of Pharmacy. 2014; 3(5): 388-396.
41. Rama B, Sandhiya V, Rathnam G, Ubaidulla U, Roy PS, Swetha M et al. Chronopharmacotherapeutic release of HMG-COA reductase inhibitor: using novel coating technique. World Journal of Pharmaceutical Research. 2016; 5(5): 784-797.
42. Harshitha R, Potturi PK, Ramesh R, Rajkumar N, Nagaraja G and Murthy PNVN et al. Development of time programmed pulsincap system for chronotherapeutic delivery of Diclofenac sodium. Research Journal of Pharmacy and Technology. 2010; 3(1): 234-238.
43. Peppas NA, Ritger PL. A simple equation for description of solute release ii. Fickian and anomalous release from swellable devices. Journal of Controlled Release, 1987; 5: 37-42.
44. Siepmann J, Siepmann F. Mathematical modeling of drug delivery. International Journal of Pharmaceutics. 2008; 364: 328-343.